Admission Date:  [**2131-7-24**]              Discharge Date:   [**2131-7-29**]  Date of Birth:  [**2079-8-25**]             Sex:   M  Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1283**] Chief Complaint: asymptomatic  Major Surgical or Invasive Procedure: AVR, ascending aorta/hemiarch replacement [**7-24**] ( 27 mm Magna CE pericardial valve, 26 mm Gelweave graft)   History of Present Illness: 51 yo male with bicuspid aortic valve and dilated asc.
4.5-4.6cm, effective forward LVEF 47%, mod.
Social History: lives with wife and 2 children [**Last Name (un) **] socially no tobacco last dental exam 1.5 years ago owns consulting business  Family History: mother with PCI in 70's  Physical Exam: HR 68  RR 20   143/86  5'[**36**]"   97.5 kg NAD skin/HEENT unremarkable neck supple with full ROM and no carotid bruits CTAB RRR no murmur abd soft, Nt, ND extrems warm and well-perfused with no edema or varicosities neuro grossly intact 2+ bilat fems/DP/PT/radials  Pertinent Results: [**2131-7-29**] 05:19AM BLOOD WBC-7.7 RBC-3.33* Hgb-10.4* Hct-29.4* MCV-88 MCH-31.1 MCHC-35.2* RDW-13.7 Plt Ct-312# [**2131-7-29**] 05:19AM BLOOD Plt Ct-312# [**2131-7-29**] 05:19AM BLOOD Glucose-137* UreaN-15 Creat-0.9 Na-137 K-4.6 Cl-100 HCO3-27 AnGap-15 [**2131-7-27**] 10:55AM BLOOD Mg-2.3 [**2131-7-26**] 07:15AM BLOOD Calcium-7.9* Phos-3.1 Mg-1.8  FINAL REPORT   HISTORY: Effusion.
Aortic valve bioprosthesis in situ.
Ascending aortic graft in situ.
I certify that I was present for this procedure in compliance with HCFA regulations.
Electronically signed by [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 4901**], MD, Interpreting physician    Brief Hospital Course: Admitted on [**7-24**] and underwent AVR/ replacement of asc.
Transferred to the CSRU in stable condition on insulin and propofol drips.
Extubated that evening and off all drips on POD #1.
Chest tubes, pacing wires and foley removed.
Beta blockade titrated for better HR and BP management, and gentle diuresis continued.
Medications on Admission: glyburide 2.5 mg [**Hospital1 **] atenolol 25 mg [**Hospital1 **] benicar 20 mg daily vits.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO every 4-6 hours as needed for pain.
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Glyburide 2.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 5 days.
Atenolol 25 mg Tablet Sig: One (1) Tablet PO twice a day.
Potassium Chloride 10 mEq Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO Q12H (every 12 hours) for 5 days.
Disp:*20 Capsule, Sustained Release(s)* Refills:*0*   Discharge Disposition: Home With Service  Facility: [**Company 1519**]  Discharge Diagnosis: Aortic valve replacement (tissue valve), ascending aorta/hemiarch replacement for bicuspid AV with mild AI.
Shower, no baths, no lotions, creams or powders to incisions.
